Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer

Authors: Monica K. VanKlompenberg, Claire O. Bedalov, Katia Fernandez Soto, Jenifer R. Prosperi

Published in: BMC Cancer | Issue 1/2016

Login to get access

Excerpt

After publication of the original article [1], it is noticed that all the Figures in the HTML version of the article are incorrect, please see the correct figures below. We apologize for any inconvenience caused. …
Literature
1.
Metadata
Title
Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
Authors
Monica K. VanKlompenberg
Claire O. Bedalov
Katia Fernandez Soto
Jenifer R. Prosperi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2950-5

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue

Research article

Insulin growth factor 1 like receptor (IGF-1R)

Research article

Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinoma

Research article

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

Research Article

Conservation of immune gene signatures in solid tumors and prognostic implications

Case report

A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma

Research article

Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits